A novel and oral histone deacetylase inhibitor, resminostat, effectively suppresses the growth of non-small cell lung cancer in a xenograft mouse model

被引：1
|
作者：
Takagi, Akimitsu [1 ]
Konishi, Hiroaki [1 ]
Tsugane, Momomi [1 ]
Taniguchi, Keisuke [1 ]
Takahashi, Hiroyuki [2 ]
Inutake, Yu [2 ]
Watanabe, Akinobu [2 ]
Kodaira, Hiroshi [2 ]
Matsuzaki, Takeshi [1 ]
机构：
[1] Yakult Honsha Co Ltd, Yakult Cent Inst Microbiol Res, Tokyo, Japan
[2] Yakult Honsha Co Ltd, Pharmaceut Res & Dev Dept, Tokyo, Japan
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-5534
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5534
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antitumor effects of a novel histone deacetylase inhibitor (chidamide) on non-small cell lung cancer cell lines
    Han, X.
    Zhang, N.
    Yao, J.
    Shi, Y.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S41 - S41
  • [2] Anwulignan is a novel JAK1 inhibitor that suppresses non-small cell lung cancer growth
    Xie, Xiaomeng
    Wang, Xiangyu
    Shi, Xiaodan
    Zhang, Yuanyuan
    Laster, Kyle Vaughn
    Liu, Kangdong
    Dong, Zigang
    Kim, Dong Joon
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (05) : 2645 - 2654
  • [3] Targeting the invasive phenotype of cisplatin-resistant Non-Small Cell Lung Cancer cells by a novel histone deacetylase inhibitor
    Zuco, Valentina
    Cassinelli, Giuliana
    Cossa, Giacomo
    Gatti, Laura
    Favini, Enrica
    Tortoreto, Monica
    Cominetti, Denis
    Scanziani, Eugenio
    Castiglioni, Vittoria
    Cincinelli, Raffaella
    Giannini, Giuseppe
    Zunino, Franco
    Zaffaroni, Nadia
    Lanzi, Cinzia
    Perego, Paola
    [J]. BIOCHEMICAL PHARMACOLOGY, 2015, 94 (02) : 79 - 90
  • [4] In vivo enrichment of cancer stem cells in histone deacetylase inhibitor resistant xenograft of lung cancer in mouse model
    Kuo, Wei-Ying
    Hwu, Luen
    Wu, Chun-Yi
    Wang, Hsin-Ell
    Liu, Ren-Shyan
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [5] Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer
    Denlinger, CE
    Keller, MD
    Mayo, MW
    Broad, RM
    Jones, DR
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (04): : 1078 - 1086
  • [6] Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
    Mamdani, Hirva
    Jalal, Shadia, I
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [7] A novel allosteric inhibitor of phosphoglycerate mutase 1 suppresses growth and metastasis of non-small cell lung cancer
    Shen, Y.
    Liang, Q.
    Luo, M. Y.
    Chen, H. Z.
    Zhou, L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S45 - S45
  • [8] Priming of non-small cell lung cancer (NSCLC) cell lines to erlotinib by the histone deacetylase (HDAC) inhibitor panobinostat
    Greve, G.
    Schiffmann, I.
    Luebbert, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 67 - 67
  • [9] In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines
    Loprevite, M
    Tiseo, M
    Grossi, F
    Scolaro, T
    Semino, C
    Pandolfi, A
    Favoni, R
    Ardizzoni, A
    [J]. ONCOLOGY RESEARCH, 2005, 15 (01) : 39 - 48
  • [10] Antitumor Efficacy of Histone Deacetylase Inhibitor or in Combination with EGFR-TKI in Non-Small Cell Lung Cancer Cell Lines
    Han, Xiaohong
    Zhang, Ningning
    Yao, Jiarui
    Shi, Yuankai
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S484 - S484
12345